Business Services
Pharmaceutical Business Services – News, analysis and company profiles
Health experts report more symptoms of long COVID-19
May 5, 2022 Business Services
According to health experts, many COVID-19 patients are still suffering the effects of the condition months after they first started …
FDA approval for first in vitro diagnostic for early Alzheimer’s detection
May 5, 2022 Business Services
The US FDA has approved the first in vitro diagnostic to aid in the early detection of Alzheimer’s disease (AD). …
OMass Therapeutics raises $100 million to progress immunology and rare diseases drug pipeline
April 28, 2022 Business Services
OMass Therapeutics have announced the $100 million (£75.5 million) Series B financing to progress its drug pipeline in immunology and …
NOCIRA announces breakthrough device designation by FDA for migraine treatment
April 28, 2022 Business Services
NOCIRA is the first company to announce the FDA’s Breakthrough Device designation for the treatment of migraine attacks in both …
NIHR-supported trial reveals vaccine boosters maintain immunity three months on
April 21, 2022 Business Services
Latest results form the UK’s COV-BOOST study, led by University Hospital Southampton, have shown prolonged immune responses following third doses …
FDA’s Cancer Advisory Committee to evaluate safety of P13K inhibitors
April 21, 2022 Business Services
The FDA’s Oncologic Drugs Advisory Committee is holding a meeting today to discuss safety findings across the entire class of …
PacBio and Children’s Mercy Kansas City expand collaboration in rare disease
April 21, 2022 Business Services
PacBio has announced an expanded research collaboration with Children’s Mercy Kansas City, to use the multi-omics capabilities of PacBio’s Sequel …
New Programme to tackle health disparities and inequalities for women with heart failure
April 21, 2022 Business Services
Women diagnosed with heart failure have worse outcomes compared to men, in spite of a similar prevalence of the chronic …
Kintor’s antiviral shows protection in mild-to-moderate COVID-19
April 7, 2022 Business Services
Kintor Pharmaceutical, based in Suzhou, China, has announced top-line results from its Phase III MRCT trial of proxalutamide in outpatients …
Blood clot risk higher for six months after having COVID-19
April 7, 2022 Business Services
A study from Sweden suggests that after a COVID-19 infection, there is an increased risk of developing a serious blood …
Eligible patients in the UK granted early access for radioligand therapy in advanced prostate cancer
April 7, 2022 Business Services
Advanced Accelerator Applications (AAA), a Novartis company, has announced that eligible patients in the UK have been granted early access …
Global Paediatric Drug Development Centre of Excellence opened in Dublin’s North Dock
April 7, 2022 Business Services
Gilead Sciences announced on April 6th the formal opening of its Dublin city centre office, focused on developing new paediatric …
FlyPharma Conference Europe: New dates and location announced
April 4, 2022 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
FlyPharma Conferences are pleased to announce that FlyPharma Europe is returning as a live, in-person event in 2022.
FDA approval of Cabenuva for adolescents living with HIV
March 31, 2022 Business Services
ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …
Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma
March 31, 2022 Business Services
An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
